Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90)-Reference-Cited by-同舟云学术

Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90)

Published:1997-06 Issue:7 Volume:33 Page:1017-1024
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Thürlimann B.,Castiglione M.,Hsu-Schmitz S.F.,Cavalli F.,Bonnefoi H.,Fey M.F.,Morant R.,Löhnert T.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Trends in Cancer Incidence and Mortality;Cooleman;IARC Publ. 121,1993

2. On the treatment of inoperable cases of carcinoma of the mamma. Suggestions for a new method of treatment with illustrative cases;Beatson;Lancet,1986

3. Formestane;Toyce;Drugs of the Future,1993

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two perspectives on venous thromboembolism in oncology;Vnitřní lékařství;2017-06-01

2. Clinical utility of exemestane in the treatment of breast cancer ;International Journal of Women's Health;2015-05

3. Endocrine therapy for advanced disease;Handbook of Metastatic Breast Cancer;2011-10-19

4. Endocrine Treatment for Metastatic Breast Cancer;Emerging Cancer Therapeutics;2010-12-01

5. Stratégies thérapeutiques des cancers du sein métastatiques : RH+ HER2−. Hormonothérapies, chimiothérapies (monochimiothérapies séquentielles ou polychimiothérapies concomitantes ?), antiangiogéniques;Cancer du sein en situation métastatique;2010